Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia
Authors
Keywords
Schizophrenia, Pregnenolone, Neurosteroid, Allopregnanolone, Function, UPSA, Cognition, MCCB, Treatment, Therapeutic, RCT
Journal
PSYCHOPHARMACOLOGY
Volume 231, Issue 17, Pages 3647-3662
Publisher
Springer Nature
Online
2014-07-16
DOI
10.1007/s00213-014-3673-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allopregnanolone Elevations Following Pregnenolone Administration Are Associated with Enhanced Activation of Emotion Regulation Neurocircuits
- (2013) Rebecca K. Sripada et al. BIOLOGICAL PSYCHIATRY
- Applicability of the MATRICS Consensus Cognitive Battery in Singapore
- (2013) Attilio Rapisarda et al. CLINICAL NEUROPSYCHOLOGIST
- Pregnenolone activates CLIP-170 to promote microtubule growth and cell migration
- (2013) Jui-Hsia Weng et al. Nature Chemical Biology
- Neurosteroids as regenerative agents in the brain: therapeutic implications
- (2013) Roberta D. Brinton Nature Reviews Endocrinology
- Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats
- (2013) Donatella Caruso et al. PSYCHONEUROENDOCRINOLOGY
- Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices
- (2012) Yasuhiro Ishihara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia
- (2012) Marie Bicikova et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Pregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice
- (2012) Peiyan Wong et al. PLoS One
- Evaluation of Functionally Meaningful Measures for Clinical Trials of Cognition Enhancement in Schizophrenia
- (2011) Michael F. Green et al. AMERICAN JOURNAL OF PSYCHIATRY
- Allopregnanolone Prevents Dieldrin-Induced NMDA Receptor Internalization and Neurotoxicity by Preserving GABAAReceptor Function
- (2011) Víctor Briz et al. ENDOCRINOLOGY
- Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice
- (2011) Chanpreet Singh et al. NEUROBIOLOGY OF AGING
- Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence
- (2011) C.E. Marx et al. NEUROSCIENCE
- Investigation of the mechanisms of progesterone protection following oxygen–glucose deprivation in organotypic hippocampal slice cultures
- (2011) Elizabeth Radley et al. NEUROSCIENCE LETTERS
- Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease
- (2011) Shuhua Chen et al. PLoS One
- Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
- (2011) Daniel C. Javitt et al. SCHIZOPHRENIA RESEARCH
- GABA Neuron Alterations, Cortical Circuit Dysfunction and Cognitive Deficits in Schizophrenia
- (2011) Guillermo Gonzalez-Burgos et al. NEURAL PLASTICITY
- Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects
- (2010) Jennifer C. Naylor et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder
- (2010) Michael S. Ritsner et al. JOURNAL OF CLINICAL PSYCHIATRY
- Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease
- (2010) J. M. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?
- (2010) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial
- (2010) Richard S.E. Keefe et al. SCHIZOPHRENIA RESEARCH
- Performance-Based Measurement of Functional Disability in Schizophrenia: A Cross-National Study in the United States and Sweden
- (2009) Philip D. Harvey et al. AMERICAN JOURNAL OF PSYCHIATRY
- Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia
- (2009) Christine E Marx et al. NEUROPSYCHOPHARMACOLOGY
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pregnenolone protects the PC-12 cell line against amyloid beta peptide toxicity but its sulfate ester does not
- (2008) Pinar Akan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cerebrospinal Fluid Dehydroepiandrosterone Levels Are Correlated with Brain Dehydroepiandrosterone Levels, Elevated in Alzheimer’s Disease, and Related to Neuropathological Disease Stage
- (2008) Jennifer C. Naylor et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Regulatory role of cytochrome P450scc and pregnenolone in myelination by rat Schwann cells
- (2008) Thant S. Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production
- (2007) Lena Danovich et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started